doi: 10.1097/01.tp.0000296680.75175.67.
Alemtuzumab
Affiliations
- PMID: 18165760
- DOI: 10.1097/01.tp.0000296680.75175.67
Item in Clipboard
Alemtuzumab
Transplantation.
.
Abstract
Alemtuzumab is a humanized CD52-specific monoclonal antibody that is increasingly used off-label as an induction agent in solid organ transplantation, particularly in the setting of maintenance immunosuppression minimization protocols. In this review, we briefly discuss this agent's mechanisms of action and summarize evidence supporting its use in this clinical setting.
Similar articles
-
Alemtuzumab in solid organ transplantation and in composite tissue allotransplantation.Immunotherapy. 2010 Nov;2(6):783-90. doi: 10.2217/imt.10.68. Immunotherapy. 2010. PMID: 21091110 Review.
-
The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation.Transpl Int. 2006 Sep;19(9):705-14. doi: 10.1111/j.1432-2277.2006.00343.x. Transpl Int. 2006. PMID: 16918530 Review.
-
The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation.Transpl Immunol. 2008 Nov;20(1-2):6-11. doi: 10.1016/j.trim.2008.09.003. Epub 2008 Sep 29. Transpl Immunol. 2008. PMID: 18824230
-
Efficacy of alemtuzumab in organ transplantation: current clinical status.BioDrugs. 2006;20(2):85-92. doi: 10.2165/00063030-200620020-00003. BioDrugs. 2006. PMID: 16626166 Review.
-
Alemtuzumab (Campath-1H) induction in a pediatric heart transplant: successful outcome and rationale for its use.J Heart Lung Transplant. 2008 Feb;27(2):242-4. doi: 10.1016/j.healun.2007.11.569. J Heart Lung Transplant. 2008. PMID: 18267235
Cited by
-
Lymphocyte depletion in experimental hemorrhagic shock in Swine.J Inflamm (Lond). 2012 Sep 25;9(1):34. doi: 10.1186/1476-9255-9-34. J Inflamm (Lond). 2012. PMID: 23009382 Free PMC article.
-
Th17 mediated alloreactivity is facilitated by the pre-transplant microbial burden of the recipient.Bone Marrow Res. 2012;2012:960280. doi: 10.1155/2012/960280. Epub 2012 Oct 9. Bone Marrow Res. 2012. PMID: 23091728 Free PMC article.
-
Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.Bone Marrow Transplant. 2011 Jan;46(1):98-104. doi: 10.1038/bmt.2010.65. Epub 2010 Apr 12. Bone Marrow Transplant. 2011. PMID: 20383216 Free PMC article. Clinical Trial.
-
Pancreatic islet transplantation: toward definitive treatment for diabetes mellitus.Glob Health Med. 2020 Aug 31;2(4):200-211. doi: 10.35772/ghm.2020.01057. Glob Health Med. 2020. PMID: 33330809 Free PMC article. Review.
-
Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes.Transplantation. 2008 Dec 27;86(12):1695-701. doi: 10.1097/TP.0b013e31819025e5. Transplantation. 2008. PMID: 19104407 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
